For: | Damiani G, Franchi C, Pigatto P, Altomare A, Pacifico A, Petrou S, Leone S, Pace MC, Fiore M. Outcomes assessment of hepatitis C virus-positive psoriatic patients treated using pegylated interferon in combination with ribavirin compared to new Direct-Acting Antiviral agents. World J Hepatol 2018; 10(2): 329-336 [PMID: 29527268 DOI: 10.4254/wjh.v10.i2.329] |
---|---|
URL: | https://www.wjgnet.com/1948-5182/full/v10/i2/329.htm |
Number | Citing Articles |
1 |
Liyun Sun, Xinwei Guo, Yeping Qin, Ping Li, Chunxia Yu, Xuesong Gao, Xinran Xie, Xuying Xu. Serum Intestinal Metabolites are Raised in Patients with Psoriasis and Metabolic Syndrome. Clinical, Cosmetic and Investigational Dermatology 2022; : 879 doi: 10.2147/CCID.S351984
|
2 |
Yong Liu, Sheng Nan Cui, Meng Yao Duan, Zhi Li Dou, Yi Zhen Li, Yi Xing Liu, Ye Xia, Jia Wei Zhang, Xiao Ning Yan, Dong Ran Han. Is there a relationship between psoriasis and hepatitis C? A meta-analysis and bioinformatics investigation. Virology Journal 2021; 18(1) doi: 10.1186/s12985-021-01606-z
|
3 |
Stefano Piaserico, Francesco Messina, Francesco Paolo Russo. Managing Psoriasis in Patients with HBV or HCV Infection: Practical Considerations. American Journal of Clinical Dermatology 2019; 20(6): 829 doi: 10.1007/s40257-019-00457-3
|
4 |
Hristina Kocic, Giovanni Damiani, Bojana Stamenkovic, Michael Tirant, Andrija Jovic, Danica Tiodorovic, Ketty Peris. Dietary compounds as potential modulators of microRNA expression in psoriasis. Therapeutic Advances in Chronic Disease 2019; 10 doi: 10.1177/2040622319864805
|
5 |
Farah Asa’ad, Marco Fiore, Aniello Alfieri, Paolo Daniele Maria Pigatto, Chiara Franchi, Emilio Berti, Carlo Maiorana, Giovanni Damiani. Saliva as a Future Field in Psoriasis Research. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/7290913
|
6 |
Xuanwei Zheng, Qiaolin Wang, Yan Luo, Wenhua Lu, Liping Jin, Menglin Chen, Wu Zhu, Yehong Kuang. Seasonal Variation of Psoriasis and Its Impact in the Therapeutic Management: A Retrospective Study on Chinese Patients. Clinical, Cosmetic and Investigational Dermatology 2021; : 459 doi: 10.2147/CCID.S312556
|
7 |
Rattapol Pakchotanon, Justine Yang Ye, Richard J. Cook, Vinod Chandran, Dafna D. Gladman. Liver Abnormalities in Patients with Psoriatic Arthritis. The Journal of Rheumatology 2020; 47(6): 847 doi: 10.3899/jrheum.181312
|
8 |
Joanna Czerwińska, Marta Kasprowicz-Furmańczyk, Waldemar Placek, Agnieszka Owczarczyk-Saczonek. Changes in Tumor Necrosis Factor α (TNFα) and Peptidyl Arginine Deiminase 4 (PAD-4) Levels in Serum of General Treated Psoriatic Patients. International Journal of Environmental Research and Public Health 2022; 19(14): 8723 doi: 10.3390/ijerph19148723
|
9 |
Chia-Yu Liu, Tao-Hsin Tung, Chin-Yu Lee, Kuo-Hsuan Chang, Shu-Hui Wang, Ching-Chi Chi. Association of Multiple Sclerosis with Psoriasis: A Systematic Review and Meta-Analysis of Observational Studies. American Journal of Clinical Dermatology 2019; 20(2): 201 doi: 10.1007/s40257-018-0399-9
|
10 |
Giovanni DAMIANI, Simone CAZZANIGA, Luigi NALDI. Use of fumaric acid derivatives in Italian reference centers for psoriasis. Italian Journal of Dermatology and Venereology 2021; 156(1) doi: 10.23736/S2784-8671.18.06032-7
|
11 |
Alessio Mylonas, Curdin Conrad. Psoriasis: Classical vs. Paradoxical. The Yin-Yang of TNF and Type I Interferon. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.02746
|
12 |
Ayman Abdelmaksoud, Michelangelo Vestita. Direct acting antiviral‐induced/exacerbated psoriasis: Addendum!. Dermatologic Therapy 2019; : e12929 doi: 10.1111/dth.12929
|
13 |
Waleed A. Ismail, Ayman E. Yousef. Effect of sofosbuvir plus daclatasvir for treatment of chronic hepatitis C on patients with psoriasis. European Journal of Gastroenterology & Hepatology 2019; 31(8): 1025 doi: 10.1097/MEG.0000000000001370
|
14 |
Shu-Hui Wang, Jui Wang, Ching-Chi Chi, Yu-Sheng Lin, Shih-Cheng Liao, Pei-En Chen, Tao-Hsin Tung. Risk for Suicidal Behavior Among Psoriasis Patients: A Nationwide Cohort Study. American Journal of Clinical Dermatology 2020; 21(3): 431 doi: 10.1007/s40257-019-00489-9
|
15 |
Jalal Moludi, Hamed Khedmatgozar, Somayeh Saiedi, Hamidreza Razmi, Mohammad Alizadeh, Behzad Ebrahimi. Probiotic supplementation improves clinical outcomes and quality of life indicators in patients with plaque psoriasis: A randomized double-blind clinical trial. Clinical Nutrition ESPEN 2021; 46: 33 doi: 10.1016/j.clnesp.2021.09.004
|
16 |
Giovanni Damiani, Alessia Pacifico, Egeria Scoditti, Sara di Gregorio, Massimo Del Fabbro, Claudia Cozzolino, Alessandra Buja, Santo R. Mercuri, Vittoria G. Bianchi, Ayman Grada, Sergio Garbarino, Christopher G. Bunick. Circadian Oscillations of Minimal Erythema Dose (MED) are Also Influenced by Diet in Patients with Psoriasis: A Chronomedical Study. Dermatology and Therapy 2023; 13(10): 2229 doi: 10.1007/s13555-023-00987-z
|
17 |
Ilaria Controne, Egeria Scoditti, Alessandra Buja, Alessia Pacifico, Khalaf Kridin, Massimo Del Fabbro, Sergio Garbarino, Giovanni Damiani. Do Sleep Disorders and Western Diet Influence Psoriasis? A Scoping Review. Nutrients 2022; 14(20): 4324 doi: 10.3390/nu14204324
|
18 |
Pierachille Santus, Maurizio Rizzi, Dejan Radovanovic, Andrea Airoldi, Andrea Cristiano, Rosalynn Conic, Stephen Petrou, Paolo Daniele Maria Pigatto, Nicola Bragazzi, Delia Colombo, Mohamad Goldust, Giovanni Damiani. Psoriasis and Respiratory Comorbidities: The Added Value of Fraction of Exhaled Nitric Oxide as a New Method to Detect, Evaluate, and Monitor Psoriatic Systemic Involvement and Therapeutic Efficacy. BioMed Research International 2018; 2018: 1 doi: 10.1155/2018/3140682
|
19 |
Shammy Jindal, Rajendra Awasthi, Dhananjay Singhare, Giriraj T. Kulkarni. Topical delivery of Tacrolimus using liposome containing gel: An emerging and synergistic approach in management of psoriasis. Medical Hypotheses 2020; 142: 109838 doi: 10.1016/j.mehy.2020.109838
|
20 |
Takashi Kida, Atsushi Umemura, Shunya Kaneshita, Risa Sagawa, Takuya Inoue, Shogo Toyama, Makoto Wada, Masataka Kohno, Ryo Oda, Tohru Inaba, Yoshito Itoh, Yutaka Kawahito. Effectiveness and safety of chronic hepatitis C treatment with direct-acting antivirals in patients with rheumatic diseases: A case-series. Modern Rheumatology 2020; 30(6): 1009 doi: 10.1080/14397595.2019.1682787
|
21 |
Giovanni Damiani, Giulia Odorici, Alessia Pacifico, Aldo Morrone, Rosalynn R. Z. Conic, Tima Davidson, Abdulla Watad, Paolo D. M. Pigatto, Delia Colombo, Piergiorgio Malagoli, Marco Fiore. Secukinumab Loss of Efficacy Is Perfectly Counteracted by the Introduction of Combination Therapy (Rescue Therapy): Data from a Multicenter Real-Life Study in a Cohort of Italian Psoriatic Patients That Avoided Secukinumab Switching. Pharmaceuticals 2022; 15(1): 95 doi: 10.3390/ph15010095
|
22 |
Ayman Abdelmaksoud, Michelangelo Vestita. Anti-HCV for treatment of HCV-positive psoriatic patients: A promising therapy. Dermatologic Therapy 2018; 31(6): e12736 doi: 10.1111/dth.12736
|
23 |
Marco Diani, Silvia Perego, Veronica Sansoni, Lucrezia Bertino, Marta Gomarasca, Martina Faraldi, Paolo Daniele Maria Pigatto, Giovanni Damiani, Giuseppe Banfi, Gianfranco Altomare, Giovanni Lombardi. Differences in Osteoimmunological Biomarkers Predictive of Psoriatic Arthritis among a Large Italian Cohort of Psoriatic Patients. International Journal of Molecular Sciences 2019; 20(22): 5617 doi: 10.3390/ijms20225617
|
24 |
Giovanni Damiani, Rosalynn R. Z. Conic, Valerio de Vita, Antonio Costanzo, Roberto Regazzini, Paolo D. M. Pigatto, Nicola L. Bragazzi, Alessia Pacifico, Piergiorgio Malagoli. When IL‐17 inhibitors fail: Real‐life evidence to switch from secukinumab to adalimumab or ustekinumab. Dermatologic Therapy 2019; 32(2): e12793 doi: 10.1111/dth.12793
|
25 |
Endeshaw Chekol Abebe, Zelalem Tilahun Muche, Awgichew Behaile T/Mariam, Teklie Mengie Ayele, Melaku Mekonnen Agidew, Muluken Teshome Azezew, Edgeit Abebe Zewde, Tadesse Asmamaw Dejenie. Role of Fetuin-A in the Pathogenesis of Psoriasis and Its Potential Clinical Applications. Clinical, Cosmetic and Investigational Dermatology 2022; : 595 doi: 10.2147/CCID.S356801
|